These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6105223)

  • 21. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
    Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
    Jpn J Antibiot; 1986 Apr; 39(4):979-90. PubMed ID: 3761551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [14C]cadralazine: absorption, distribution and excretion in rat and dog.
    Bonardi G; Rossi E; Pellegatti M
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):25-33. PubMed ID: 6861793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on absorption, distribution and excretion of 14C labeled (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluene-sulfonate hydrate (14C-T-3262) in rats and mice].
    Maeda T; Sakai H; Hayakawa H; Hayashi K; Yoneda K
    Jpn J Antibiot; 1989 Apr; 42(4):854-67. PubMed ID: 2769938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic and pharmacokinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung.
    Chand N; Adusumalli VE; Nolan K; Diamantis W; Wichmann JK; Pivonka J; Langevin CN; Wong KK; Kucharczyk N; Sofia RD
    Allergy; 1993 Jan; 48(1):19-24. PubMed ID: 8096126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration.
    Nakamura A; Hirota T; Sugihara K; Watanabe S; Tougou K; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):160-8. PubMed ID: 9079235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Noguchi M; Yamauchi H; Shimizu H
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of flutropium bromide, a new antiasthma drug, with repeated administration on bronchomotor response and hepatic drug metabolizing enzymes].
    Mizuno H; Kawabata N; Ohno H; Misawa M
    Nihon Yakurigaku Zasshi; 1989 Jun; 93(6):333-40. PubMed ID: 2567689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the physiological disposition and pharmacokinetics of 7-N-(p-hydroxyphenyl)-mitomycin C].
    Okumura S; Deguchi T; Nakamizo N
    Jpn J Antibiot; 1982 Aug; 35(8):1967-76. PubMed ID: 7154244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of 4-acetylaminophenylacetic acid. 2nd communication: tissue accumulation and enzyme induction in rats after repeated administration, and placental and milk transfer after single dosing.
    Sugihara K; Morino A; Sugiyama M; Iida S; Nomura A
    Arzneimittelforschung; 1990 Jul; 40(7):806-10. PubMed ID: 2222557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption, distribution and excretion of 14C-pilocarpine following oral administration to rats.
    Omori Y; Endo T; Hara Y; Nishiyama M; Midgley I; Smart CI; John AJ; Chasseaud LF; McBurney A; John BA
    Arzneimittelforschung; 2004; 54(3):171-8. PubMed ID: 15112864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution and lung localization of [14C]azelastine in guinea pigs.
    Wong KK; Yang JT; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1992; 20(4):525-9. PubMed ID: 1356729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.